- Home
- BBIO vs ELP Comparison
BBIO vs ELP Comparison
Compare BBIO & ELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- ELP
- Stock Information
- Founded
- BBIO 2015
- ELP 1954
- Country
- BBIO United States
- ELP Brazil
- Employees
- BBIO N/A
- ELP N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- ELP Electric Utilities: Central
- Sector
- BBIO Health Care
- ELP Utilities
- Exchange
- BBIO Nasdaq
- ELP Nasdaq
- Market Cap
- BBIO 5.6B
- ELP 5.5B
- IPO Year
- BBIO 2019
- ELP 1997
- Fundamental
- Price
- BBIO $36.85
- ELP $7.11
- Analyst Decision
- BBIO Strong Buy
- ELP
- Analyst Count
- BBIO 12
- ELP 0
- Target Price
- BBIO $52.27
- ELP N/A
- AVG Volume (30 Days)
- BBIO 2.7M
- ELP 234.3K
- Earning Date
- BBIO 02-20-2025
- ELP 02-27-2025
- Dividend Yield
- BBIO N/A
- ELP 4.22%
- EPS Growth
- BBIO N/A
- ELP 43.89
- EPS
- BBIO N/A
- ELP 0.19
- Revenue
- BBIO $221,902,000.00
- ELP $4,076,906,276.00
- Revenue This Year
- BBIO $2,306.75
- ELP N/A
- Revenue Next Year
- BBIO N/A
- ELP $9.40
- P/E Ratio
- BBIO N/A
- ELP $8.95
- Revenue Growth
- BBIO 2285.27
- ELP 4.83
- 52 Week Low
- BBIO $21.62
- ELP $5.72
- 52 Week High
- BBIO $39.47
- ELP $8.34
- Technical
- Relative Strength Index (RSI)
- BBIO 63.77
- ELP 64.20
- Support Level
- BBIO $35.36
- ELP $7.05
- Resistance Level
- BBIO $39.47
- ELP $7.31
- Average True Range (ATR)
- BBIO 1.93
- ELP 0.13
- MACD
- BBIO 0.26
- ELP 0.02
- Stochastic Oscillator
- BBIO 70.79
- ELP 68.94
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About ELP Companhia Paranaense de Energia (COPEL) (each representing one Unit consisting one Common Share and four non-voting Class B Preferred Shares)
Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Holding and Services. Majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.